Evidence map›Paper›PMID 38871861›Full record

ArticleMolecular biomedicine2024

Ckip-1 3'UTR alleviates prolonged sleep deprivation induced cardiac dysfunction by activating CaMKK2/AMPK/cTNI pathway.

Beilei Dong, Rui Xue, Jianwei Li, Shukuan Ling, Wenjuan Xing, Zizhong Liu, Xinxin Yuan, Junjie Pan, Ruikai Du, Xinming Shen and 4 more

Abstract read
In one paragraph

Article in Molecular biomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Potential mechanisms underlying pathological fatigue-induced cardiac dysfunction.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Beilei DongNanjing University of Chinese Medicine, Nanjing, 210023, China.
Rui XueBeijing Institute of Pharmacology and Toxicology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing, 100850, China. hly19830718@sina.com.
Jianwei LiNational Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing, 100094, China.
Shukuan LingOujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, Zhejiang, 325041, China.
Wenjuan XingNational Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing, 100094, China.
Zizhong LiuNational Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing, 100094, China.
Xinxin YuanNational Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing, 100094, China.
Junjie PanNational Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing, 100094, China.
Ruikai DuNational Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing, 100094, China.
Xinming ShenNanjing University of Chinese Medicine, Nanjing, 210023, China.
Jingwen ZhangBeijing Institute of Pharmacology and Toxicology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing, 100850, China.
Youzhi ZhangBeijing Institute of Pharmacology and Toxicology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing, 100850, China. bcczyz@163.com.
Yingxian LiNational Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing, 100094, China. yingxianli@aliyun.com.ORCID 0000-0002-5440-3281
Guohui ZhongNational Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing, 100094, China. guohuiacc@163.com.

Funding

National Key Research and Development Project 2022YFA1104203National Natural Science Foundation of China 82192882
6 · The paper itself

Abstract

Sleep deprivation (SD) has emerged as a critical concern impacting human health, leading to significant damage to the cardiovascular system. However, the underlying mechanisms are still unclear, and the development of targeted drugs is lagging. Here, we used mice to explore the effects of prolonged SD on cardiac structure and function. Echocardiography analysis revealed that cardiac function was significantly decreased in mice after five weeks of SD. Real-time quantitative PCR (RT-q-PCR) and Masson staining analysis showed that cardiac remodeling marker gene Anp (atrial natriuretic peptide) and fibrosis were increased, Elisa assay of serum showed that the levels of creatine kinase (CK), creatine kinase-MB (CK-MB), ANP, brain natriuretic peptide (BNP) and cardiac troponin T (cTn-T) were increased after SD, suggesting that cardiac remodeling and injury occurred. Transcript sequencing analysis indicated that genes involved in the regulation of calcium signaling pathway, dilated cardiomyopathy, and cardiac muscle contraction were changed after SD. Accordingly, Western blotting analysis demonstrated that the cardiac-contraction associated CaMKK2/AMPK/cTNI pathway was inhibited. Since our preliminary research has confirmed the vital role of Casein Kinase-2 -Interacting Protein-1 (CKIP-1, also known as PLEKHO1) in cardiac remodeling regulation. Here, we found the levels of the 3' untranslated region of Ckip-1 (Ckip-1 3'UTR) decreased, while the coding sequence of Ckip-1 (Ckip-1 CDS) remained unchanged after SD. Significantly, adenovirus-mediated overexpression of Ckip-1 3'UTR alleviated SD-induced cardiac dysfunction and remodeling by activating CaMKK2/AMPK/cTNI pathway, which proposed the therapeutic potential of Ckip-1 3'UTR in treating SD-induced heart disease.

Indexed as

3' Untranslated RegionsAMP-Activated Protein KinasesCalcium-Calmodulin-Dependent Protein Kinase KinaseSignal TransductionSleep DeprivationAnimalsCarrier ProteinsIntracellular Signaling Peptides and ProteinsMaleMiceMice, Inbred C57BLMyocardiumTroponin I3' Untranslated RegionsAMP-Activated Protein KinasesCalcium-Calmodulin-Dependent Protein Kinase KinaseCamkk2 protein, mouseCarrier ProteinsIntracellular Signaling Peptides and ProteinsPLEKHO1 protein, mouseTroponin ICaMKK2/AMPK/cTNI pathwayCardiac functionCkip-1 3'UTRSleep deprivation

Identifiers

PMID38871861
PMCPMC11176284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.